| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Novel ω-3 Acid Ethyl Ester Formulation Incorporating Advanced Lipid TechnologiesTM (ALT®) Improves Docosahexaenoic Acid and Eicosapentaenoic Acid Bioavailability Compared with Lovaza®
|
Lopez-Toledano, Miguel A.
|
|
2017
|
39 |
3 |
p. 581-591
11 p.
|
artikel
|
| 2 |
A Review of the Theoretical and Biological Understanding of the Nocebo and Placebo Phenomena
|
Dodd, Seetal
|
|
2017
|
39 |
3 |
p. 469-476
8 p.
|
artikel
|
| 3 |
Bioequivalence Demonstration for Ω-3 Acid Ethyl Ester Formulations: Rationale for Modification of Current Guidance
|
Maki, Kevin C.
|
|
2017
|
39 |
3 |
p. 652-658
7 p.
|
artikel
|
| 4 |
Choosing Wisely: The Top-5 Recommendations from the Italian Panel of the National Guidelines for the Management of Acute Pharyngitis in Children
|
Chiappini, Elena
|
|
2017
|
39 |
3 |
p. 646-649
4 p.
|
artikel
|
| 5 |
Cognitive Schemas in Placebo and Nocebo Responding: Role of Autobiographical Memories and Expectations
|
Bartels, Danielle J.P.
|
|
2017
|
39 |
3 |
p. 502-512.e1
4619 p.
|
artikel
|
| 6 |
Corrigendum to ‘Demographic and Clinical Characteristics of Type 2 Diabetes Mellitus Patients Initiating Dipeptidyl Peptidase-4 Inhibitors - A Retrospective Study of UK General Practice’ Clin Ther 2016;8:1825–1832.e15
|
Tebboth, Abigail
|
|
2017
|
39 |
3 |
p. 662-662.e15
6.619999999999994E17 p.
|
artikel
|
| 7 |
Cost-effectiveness of Pazopanib Versus Sunitinib as First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma from an Italian National Health Service Perspective
|
Capri, Stefano
|
|
2017
|
39 |
3 |
p. 567-580.e2
57434 p.
|
artikel
|
| 8 |
Cost of Bleeding-related Episodes in Adult Patients With Primary Immune Thrombocytopenia: A Population-based Retrospective Cohort Study of Administrative Claims Data for Commercial Payers in the United States
|
Lin, Junji
|
|
2017
|
39 |
3 |
p. 603-609.e1
5488 p.
|
artikel
|
| 9 |
Cost-utility of First-line Disease-modifying Treatments for Relapsing–Remitting Multiple Sclerosis
|
Soini, Erkki
|
|
2017
|
39 |
3 |
p. 537-557.e10
5.569999999464E12 p.
|
artikel
|
| 10 |
Current Insights in the Placebo and Nocebo Phenomena
|
Dodd, Seetal
|
|
2017
|
39 |
3 |
p. 456-457
2 p.
|
artikel
|
| 11 |
Different Disclosed Probabilities to Receive an Antiemetic Equally Decrease Subjective Symptoms in an Experimental Placebo Study: To Be or Not to Be Sure
|
Weimer, Katja
|
|
2017
|
39 |
3 |
p. 487-501
15 p.
|
artikel
|
| 12 |
Economic Utility: Combinatorial Pharmacogenomics and Medication Cost Savings for Mental Health Care in a Primary Care Setting
|
Brown, Lisa C.
|
|
2017
|
39 |
3 |
p. 592-602.e1
5429 p.
|
artikel
|
| 13 |
Editorial Board
|
|
|
2017
|
39 |
3 |
p. A2-
1 p.
|
artikel
|
| 14 |
Effects of Oral Antidiabetic Drugs on Changes in the Liver-to-Spleen Ratio on Computed Tomography and Inflammatory Biomarkers in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
|
Yabiku, Koichi
|
|
2017
|
39 |
3 |
p. 558-566
9 p.
|
artikel
|
| 15 |
Effects of Pitavastatin on Lipid-rich Carotid Plaques Studied Using High-resolution Magnetic Resonance Imaging
|
Feng, Tao
|
|
2017
|
39 |
3 |
p. 620-629
10 p.
|
artikel
|
| 16 |
Erratum
|
Roever, Leonardo
|
|
2017
|
39 |
3 |
p. 663-
1 p.
|
artikel
|
| 17 |
Health Care Utilization and Direct Costs in Mild, Moderate, and Severe Adult Asthma: A Descriptive Study Using the 2014 South Korean Health Insurance Database
|
Lee, Yoo Ju
|
|
2017
|
39 |
3 |
p. 527-536
10 p.
|
artikel
|
| 18 |
Interleukin-10: A Compelling Therapeutic Target in Patients With Irritable Bowel Syndrome
|
Kumar, Sunil
|
|
2017
|
39 |
3 |
p. 632-643
12 p.
|
artikel
|
| 19 |
Lipid-lowering Therapy in Patients With High Cardiovascular Risk: Dose or Combination?
|
Roever, Leonardo
|
|
2017
|
39 |
3 |
p. 659-660
2 p.
|
artikel
|
| 20 |
Masthead
|
|
|
2017
|
39 |
3 |
p. A3-
1 p.
|
artikel
|
| 21 |
Phase I Randomized Placebo-controlled, Double-blind Study of the Safety and Tolerability of Bremelanotide Coadministered With Ethanol in Healthy Male and Female Participants
|
Clayton, Anita H.
|
|
2017
|
39 |
3 |
p. 514-526.e14
5.259999999999949E16 p.
|
artikel
|
| 22 |
Placebos, Active Placebos, and Clinical Trials
|
Shader, Richard I
|
|
2017
|
39 |
3 |
p. 451-454
4 p.
|
artikel
|
| 23 |
Retrospective Analysis of Different Treatment Schemes After Gefitinib Resistance in Advanced Non–small Cell Lung Cancer
|
Wang, Huijuan
|
|
2017
|
39 |
3 |
p. 610-619
10 p.
|
artikel
|
| 24 |
Table of Contents
|
|
|
2017
|
39 |
3 |
p. A4-A5
nvt p.
|
artikel
|
| 25 |
The Placebo and Nocebo Phenomena: Their Clinical Management and Impact on Treatment Outcomes
|
Chavarria, Victor
|
|
2017
|
39 |
3 |
p. 477-486
10 p.
|
artikel
|
| 26 |
Unsolved, Forgotten, and Ignored Features of the Placebo Response in Medicine
|
Enck, Paul
|
|
2017
|
39 |
3 |
p. 458-468
11 p.
|
artikel
|
Tijdschrift beschrijving